Amgen GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Apremilast, ATC L04AA32 for the period 01012025 - 31122026

Germany, Jan. 29 -- Germany based Amgen GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Apremilast, ATC L04AA32 for the period 01012025 - 31122026. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....